Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
Go back to Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test| (NASDAQ: LUCD) | Delayed: 0.78 -0.06 (7.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $ | |||
| Open | $0.82 | 52 Week Low | $ | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.75 | EPS | $ | |||
| Volume | 1,282,679 | |||||
| (NASDAQ: PAVM) | Delayed: 3.97 +0.05 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.92 | 52 Week High | $15.24 | |||
| Open | $4.02 | 52 Week Low | $10.50 | |||
| Day High | $4.06 | P/E | N/A | |||
| Day Low | $3.90 | EPS | $0.00 | |||
| Volume | 8,792 | |||||
